Clinical Trial Update: Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating amifostine with IMRT to protect salivary glands in head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED